Wednesday, July 8, 2026

Patent intelligence · US

US 9732333

Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

granted A61KA61K38/47A61PA61P11/00
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 11
Applicant portfolio 22
Patent details — US 9732333
Jurisdiction
US
Status
granted
Grant date
Aug 15, 2017
Expiration
Aug 10, 2037
Applicant
Protalix Ltd.
Claims
24
CPC classes
A61K, A61K38/47, A61P, A61P11/00
View on Google Patents ↗

Quick answer

US 9732333 (Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells) is held by Protalix Ltd.. Status: granted. Granted Aug 15, 2017. Expires Aug 10, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
Protalix Ltd.
Grant date
Expiration
Claims
24
CPC classes
A61K, A61K38/47, A61P, A61P11/00, A61P13/12, A61P17/00

More from Protalix Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 12385026

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Expires Aug 7, 2045

    granted
  2. US 12194079

    Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

    Protalix Ltd. · Expires Jan 9, 2045

    granted
  3. US 11814657

    Modified DNase and uses thereof

    Protalix Ltd. · Expires Nov 9, 2043

    granted
  4. US 11225648

    Modified DNase and uses thereof

    Protalix Ltd. · Expires Jan 13, 2042

    granted
  5. US 10870842

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Expires Dec 17, 2040

    granted
  6. US 10730925

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Expires Jul 30, 2040

    granted
  7. US 10280414

    Stabilized α-galactosidase and uses thereof

    Protalix Ltd. · Expires May 2, 2039

    granted
  8. US 10087232

    Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy

    Protalix Ltd. · Expires Sep 27, 2038

    granted

Frequently asked questions

What is US patent 9732333?

US 9732333 (Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells) is held by Protalix Ltd.. Status: granted. Granted Aug 15, 2017. Expires Aug 10, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9732333?

Protalix Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 22 pharmaceutical patents for this assignee.

When does US 9732333 expire?

Our index shows an expiration date of Aug 10, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.